| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
83,038 |
66,827 |
$8.77M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
61,348 |
52,556 |
$6.45M |
| S9083 |
Global fee urgent care centers |
65,017 |
48,221 |
$4.59M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25,485 |
25,294 |
$2.72M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
23,896 |
23,776 |
$2.48M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
8,913 |
8,096 |
$658K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
44,881 |
39,852 |
$387K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,713 |
3,514 |
$341K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
7,115 |
6,525 |
$145K |
| 99215 |
Prolong outpt/office vis |
655 |
646 |
$71K |
| 0001A |
|
952 |
949 |
$44K |
| 0002A |
|
923 |
923 |
$44K |
| 0003A |
|
828 |
828 |
$39K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,493 |
5,900 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,596 |
4,258 |
$26K |
| 0013A |
|
445 |
445 |
$22K |
| 0011A |
|
556 |
555 |
$21K |
| 0012A |
|
499 |
499 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
10,588 |
10,290 |
$17K |
| 99000 |
|
8,299 |
7,308 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,813 |
1,733 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
765 |
763 |
$13K |
| 0072A |
|
256 |
256 |
$12K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
6,722 |
6,473 |
$12K |
| 0071A |
|
247 |
246 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,097 |
5,043 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
486 |
481 |
$9K |
| 81002 |
|
4,528 |
4,345 |
$9K |
| 99441 |
|
423 |
410 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
53 |
53 |
$6K |
| 99205 |
Prolong outpt/office vis |
53 |
53 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
45 |
41 |
$5K |
| 0031A |
|
110 |
99 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
866 |
856 |
$4K |
| 0124A |
|
83 |
83 |
$4K |
| 90832 |
Psychotherapy, 30 minutes with patient |
219 |
169 |
$3K |
| 81025 |
|
2,723 |
2,655 |
$3K |
| 99497 |
|
269 |
262 |
$2K |
| 99401 |
|
1,445 |
1,374 |
$2K |
| 96127 |
|
3,183 |
3,062 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
51 |
50 |
$2K |
| 0134A |
|
31 |
31 |
$2K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,215 |
1,116 |
$1K |
| 90688 |
|
458 |
458 |
$1K |
| 0004A |
|
16 |
16 |
$820.00 |
| 93000 |
|
252 |
250 |
$810.97 |
| 99072 |
|
22,876 |
20,348 |
$795.00 |
| 90686 |
|
222 |
222 |
$635.47 |
| 80053 |
Comprehensive metabolic panel |
48 |
48 |
$625.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
709 |
688 |
$585.00 |
| 90791 |
Psychiatric diagnostic evaluation |
188 |
166 |
$450.00 |
| 87340 |
|
303 |
300 |
$416.32 |
| 86704 |
|
239 |
238 |
$412.44 |
| 80050 |
General health panel |
13 |
13 |
$409.50 |
| 87522 |
Neg quan hep c or qual rna |
344 |
340 |
$405.00 |
| 99442 |
|
18 |
18 |
$368.68 |
| 90674 |
|
79 |
79 |
$340.69 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
232 |
227 |
$303.77 |
| 86480 |
|
168 |
166 |
$301.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
102 |
100 |
$285.56 |
| 96160 |
|
135 |
116 |
$262.18 |
| 99408 |
|
1,054 |
960 |
$178.70 |
| 86703 |
|
382 |
377 |
$172.43 |
| 99173 |
|
173 |
173 |
$160.28 |
| 82607 |
|
12 |
12 |
$151.56 |
| 82746 |
|
12 |
12 |
$151.56 |
| 87428 |
|
26 |
26 |
$150.00 |
| 80061 |
Lipid panel |
36 |
36 |
$134.20 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27 |
27 |
$123.89 |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
192 |
191 |
$119.74 |
| 99406 |
|
221 |
212 |
$100.46 |
| A4770 |
Blood collection tube, vacuum, for dialysis, per 50 |
16 |
16 |
$100.25 |
| 86705 |
|
60 |
59 |
$100.00 |
| 96138 |
|
202 |
176 |
$83.13 |
| 86780 |
|
220 |
217 |
$75.98 |
| 36410 |
|
16 |
16 |
$70.18 |
| 99050 |
|
279 |
258 |
$35.74 |
| 1111F |
|
15,977 |
13,877 |
$29.48 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$25.00 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
393 |
369 |
$18.01 |
| 86592 |
|
69 |
69 |
$2.78 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,302 |
2,134 |
$0.66 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
12,346 |
10,701 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
10,523 |
8,990 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,617 |
2,328 |
$0.00 |
| 1160F |
|
2,249 |
2,088 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,044 |
984 |
$0.00 |
| G8476 |
Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg |
259 |
233 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
305 |
277 |
$0.00 |
| A4550 |
Surgical trays |
30 |
29 |
$0.00 |
| 1159F |
|
2,282 |
2,116 |
$0.00 |
| 87530 |
|
47 |
47 |
$0.00 |
| G8938 |
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible |
171 |
166 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
3,051 |
2,749 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
399 |
361 |
$0.00 |
| 97602 |
|
41 |
38 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
303 |
289 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14 |
14 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
203 |
188 |
$0.00 |
| 97803 |
|
30 |
29 |
$0.00 |
| 99080 |
|
2,087 |
842 |
$0.00 |
| 1124F |
|
352 |
341 |
$0.00 |
| 91300 |
|
21 |
20 |
$0.00 |
| G8785 |
Blood pressure reading not documented, reason not given |
33 |
32 |
$0.00 |
| S9470 |
Nutritional counseling, dietitian visit |
13 |
12 |
$0.00 |
| 99499 |
|
33 |
32 |
$0.00 |
| 4004F |
|
22 |
21 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
15 |
14 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
11,607 |
10,225 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
260 |
237 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
979 |
914 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,769 |
5,169 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
91 |
90 |
$0.00 |
| 1036F |
|
3,436 |
3,146 |
$0.00 |
| 1125F |
|
983 |
949 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
812 |
751 |
$0.00 |
| 1126F |
|
985 |
921 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
1,226 |
1,100 |
$0.00 |
| 1000F |
|
696 |
630 |
$0.00 |
| 1031F |
|
247 |
234 |
$0.00 |
| 97802 |
|
222 |
215 |
$0.00 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
117 |
109 |
$0.00 |
| 2000F |
|
309 |
298 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
78 |
78 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
67 |
66 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
154 |
145 |
$0.00 |
| G8430 |
Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) |
97 |
89 |
$0.00 |
| 3008F |
|
70 |
68 |
$0.00 |
| 1123F |
|
99 |
97 |
$0.00 |
| H2012 |
Behavioral health day treatment, per hour |
91 |
87 |
$0.00 |
| 91301 |
|
27 |
27 |
$0.00 |
| G8433 |
Screening for depression not completed, documented patient or medical reason |
13 |
13 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
15 |
15 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
45 |
44 |
$0.00 |
| 81001 |
|
14 |
14 |
$0.00 |
| A6260 |
Wound cleansers, any type, any size |
73 |
66 |
$0.00 |
| G8732 |
No documentation of pain assessment, reason not given |
27 |
27 |
$0.00 |
| G2062 |
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes |
12 |
12 |
$0.00 |